Christopher A. Blair

发表

High Sensitivity of an Ha-RAS Transgenic Model of Superficial Bladder Cancer to Metformin Is Associated with ∼240-Fold Higher Drug Concentration in Urine than Serum

M. McClelland, Xue-Ru Wu, M. Pollak, 2016, Molecular Cancer Therapeutics.

Molecular targeted approaches to cancer therapy and prevention using chalcones.

Yan-Bing Zhang, Christopher A. Blair, X. Zi, 2014, Current cancer drug targets.

Title High Sensitivity of an HaRAS Transgenic Model of Superficial Bladder Cancer to Metformin Is Associated with Â 240-Fold Higher Drug Concentration in Urine than Serum Permalink

Xiaolin, M. Pollak, Zhongbo Liu, 2016 .

Kava Components Down-Regulate Expression of AR and AR Splice Variants and Reduce Growth in Patient-Derived Prostate Cancer Xenografts in Mice

M. Lilly, Zhongbo Liu, Christopher A. Blair, 2012, PloS one.

Potential molecular targeting of splice variants for cancer treatment.

Christopher A. Blair, X. Zi, 2011, Indian journal of experimental biology.

Histone lysine-specific methyltransferases and demethylases in carcinogenesis: new targets for cancer therapy and prevention.

D. Mercola, P. Sassone-Corsi, Yan-Bing Zhang, 2013, Current cancer drug targets.

Nutraceuticals in Human Urinary Bladder Cancer Prevention and Treatment

Christopher A. Blair, X. Zi, 2012 .

Effect of perineoplasm perinephric adipose tissues on migration of clear cell renal cell carcinoma cells: a potential role of WNT signaling

N. Yokoyama, Christopher A. Blair, X. Zi, 2016, Oncotarget.

Abstract 1255: Delta-tocopherol induced endoplasmic reticulum stress causes autophagic degradation of ER and cell death in bladder cancer models

Chung S. Yang, Christopher A. Blair, X. Zi, 2018, Prevention Research.

High Sensitivity of an Ha-RAS Transgenic Model of Superficial Bladder Cancer to Metformin Is Associated with ∼240-Fold Higher Drug Concentration in Urine than Serum

Xue-Ru Wu, M. Pollak, Zhongbo Liu, 2016, Molecular Cancer Therapeutics.